[Conference presentation] Presenting the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026)

#Conference Presentations

Sysmex Corporation presented the latest data on the development of blood-based biomarkers for Alzheimer's Disease at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026) held from March 17^th to 21^st, 2026 in Copenhagen, Denmark.

[Poster presentation]

Session	Subject	Presenter (Affiliation)
Theme A: β-Amyloid Diseases SHIFT 01-454^*1	Development of a fully automated plasma p-Tau205 immunoassay demonstrating high concordance with an immunoprecipitation mass spectrometry assay Overview of presentation(PDF:142KB)The PDF file will open in a new window	Kengo Ishiki (Sysmex corporation)
Theme A: β-Amyloid Diseases SHIFT 02-412^*2	Development of predictive models for amyloid positivity using routine health check-up items in older Japanese adults Overview of presentation(PDF:142KB)The PDF file will open in a new window	Shun Murakami (Sysmex corporation)
Theme A: β-Amyloid Diseases SHIFT 02-365^*3	Blood-based prediction of CSF amyloid pathology using plasma p-Tau217 and p-Tau217/Aβ42 ratio in the SPIN cohort Overview of presentation(PDF:144KB)The PDF file will open in a new window	Yuko Mori (Sysmex R&D Center Europe GmbH)

[Poster Presentation by Prof. Charlotte Teunissen, Amsterdam UMC]

Session	Subject
Theme A: β-Amyloid Diseases SHIFT 02-431^*4	High diagnostic performance of the random-access HISCL p-Tau217, Aβ42 and Aβ40 plasma assays in detecting amyloid pathology across clinical stages Overview of presentation(PDF:145KB)The PDF file will open in a new window

Terminology